BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 9505945)

  • 1. [Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
    Glasmacher A; Just-Nübling G; Molitor E
    Dtsch Med Wochenschr; 1998 Feb; 123(7):191-4. PubMed ID: 9505945
    [No Abstract]   [Full Text] [Related]  

  • 2. [Commonly used antifungal agents in the treatment of systemic mycoses].
    Berenguer Berenguer J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
    [No Abstract]   [Full Text] [Related]  

  • 3. [Choice and use of antifungal drugs].
    Dupont B
    Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine.
    Silling G; Fegeler W; Roos N; Essink M; Büchner T
    Mycoses; 1999; 42 Suppl 2():101-4. PubMed ID: 10865914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
    Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of visceral mycoses, with special reference to drug therapy].
    Ikemoto H
    Nihon Rinsho; 1980 Nov; 38(11):4386-92. PubMed ID: 7253229
    [No Abstract]   [Full Text] [Related]  

  • 7. [Systemic mycotic infections].
    Meunier F
    Recenti Prog Med; 1990 Jan; 81(1):18-22. PubMed ID: 2173078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic antifungal drugs.
    Med Lett Drugs Ther; 1994 Feb; 36(916):16-8. PubMed ID: 8302208
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of pulmonary mycoses].
    Schaberg T; Lode H
    Dtsch Med Wochenschr; 1992 Nov; 117(45):1725-9. PubMed ID: 1330477
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
    van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Itraconazole in systemic fungal infections. Clinical profile and future trends].
    Fernández Fernández A; Esteban Montero S
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():66-70. PubMed ID: 9441309
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical manifestation and treatment of blood disease combined with invasive fungal infection].
    Shen ZX; Chen QS
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1447-8. PubMed ID: 16061018
    [No Abstract]   [Full Text] [Related]  

  • 13. [Invasive fungal infection in haematology patients].
    Vallejo Llamas JC; Ruiz-Camps I
    Enferm Infecc Microbiol Clin; 2012 Nov; 30(9):572-9. PubMed ID: 23079614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focus on fungal infections.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Jul; 3(7):27-32. PubMed ID: 11364470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment of the systemic mycoses.
    Newberry WM
    Semin Drug Treat; 1972; 2(3):313-29. PubMed ID: 4617926
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in the treatment of severe refractory infections. 4) Deep fungal infection].
    Watanabe K
    Nihon Naika Gakkai Zasshi; 1998 Nov; 87(11):2257-62. PubMed ID: 9921211
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluconazole and itraconazole: current status and prospects for antifungal therapy.
    Sugar AM
    Curr Clin Top Infect Dis; 1993; 13():74-98. PubMed ID: 8397919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.